IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 170 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $328,287 | +5.4% | 30,854 | +4.2% | 0.04% | -17.6% |
| Q1 2023 | $311,392 | -17.0% | 29,600 | -2.3% | 0.05% | +45.7% |
| Q4 2022 | $375,330 | +19.5% | 30,293 | -0.1% | 0.04% | +12.9% |
| Q3 2022 | $314,000 | -9.5% | 30,337 | +0.7% | 0.03% | -8.8% |
| Q2 2022 | $347,000 | -62.0% | 30,134 | -37.8% | 0.03% | +142.9% |
| Q2 2017 | $914,000 | – | 48,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |